8月6日，Elevance Health盘中上涨3.05%，报389.49美元/股，成交额1.42亿美元。
消息面上，公司CEO Gail Boudreaux与董事长Ramiro Peru于7月17日同日买入公司股票，被Smart Insider选为当周推荐股。CEO以每股367.79美元购入约100万美元股票，将持仓增加2%，这是其任内第三次增持，且买入价较去年7月的287美元高出约28%，被市场视为积极信号。董事长同日买入约36.6万美元股票。
此外，公司Q2业绩超预期，调整后EPS为7.45美元远超市场预期的6.21美元，并将全年调整后EPS指引上调至不低于27美元。多家机构上调目标价，Guggenheim调至455美元，Wells Fargo调至492美元，均维持看多评级。同行业中，康西哥涨5.82%，板块整体表现积极。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.